TY - JOUR T1 - Cognitive endophenotypes in racially- and ethnically-diverse middle-aged adult offspring aggregate with parental magnetic resonance imaging biomarkers of Alzheimer’s disease risk JF - medRxiv DO - 10.1101/2021.01.15.21249832 SP - 2021.01.15.21249832 AU - Patrick J. Lao AU - Indira C. Turney AU - Justina Avila-Reiger AU - Jet M.J. Vonk AU - Miguel Arce Rentería AU - Dominika Seblova AU - Anthony G. Chesebro AU - Krystal K. Laing AU - Erica Amarante AU - Michelle Martinez AU - Judes Fleurimont AU - José Gutierrez AU - Nicole Schupf AU - Richard Mayeux AU - Jennifer J. Manly AU - Adam M. Brickman Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/20/2021.01.15.21249832.abstract N2 - A family history of Alzheimer’s disease (AD) increases risk for AD in an individual by 1.5-to 3-fold. Heritability of AD risk may be due in part to the aggregation of neurodegeneration and cerebrovascular changes with cognitive endophenotypes within families. The purpose of this study was to determine the extent to which cognitive functioning in middle-aged adults is associated with objectively-measured neurodegenerative and cerebrovascular neuroimaging markers linked to risk for clinical AD in their parents, and the extent to which these associations differ by race/ethnicity and language, as proxy variables for social advantage. Middle-aged children enrolled in the Offspring study (n=356; 53.1±10.1 years old; 13% Non-Hispanic White, 27% Non-Hispanic Black, 26% Latinx tested in English, 34% Latinx tested in Spanish; 65% women; 13.5±3.4 years education) were administered the NIH Toolbox, a computerized neuropsychological battery, in their preferred language. Older adults were a subset of the Washington-Heights Inwood Columbia Aging Project (77.3±6.6 years old; 75% women; 10.0±4.6 years education) who underwent T1w- and T2w-MRI and who had a child enrolled in the Offspring study. We tested the associations of parental MRI measures reflecting neurodegeneration (hippocampal volume, cortical thickness) and cerebrovascular disease (white matter hyperintensity (WMH) volume, presence of infarct) with cognitive tests scores in Offspring participants. We further stratified the models by race/ethnicity. Better offspring cognitive scores aggregated lower parental neurodegeneration and cerebrovascular disease among Non-Hispanic White and Latinx participants, and with lower parental cerebrovascular disease alone among Non-Hispanic Black participants. Associations were generally strongest in Non-Hispanic White participants compared to the other groups. These results suggest a more consistent link between offspring cognitive endophenotype and parental brain health in intergenerational AD transmission among Non-Hispanic White participants compared to racial/ethnic and minority groups in which other social factors may be adding variance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementData collection and sharing for this project was supported by the Washington Heights-Inwood Columbia Aging Project (WHICAP, P01AG07232, R01AG037212, RF1AG054023, R56AG034189, R01AG034189, R01AG054520) and the Offspring study (RF1 AG054070, R01 AG058067) funded by the National Institute on Aging (NIA). This manuscript was also supported by K99AG065506 and has been reviewed by WHICAP and Offspring investigators for scientific content and consistency of data interpretation with previous WHICAP and Offspring Study publications. We acknowledge the WHICAP and Offspring study participants and the WHICAP and Offspring research and support staff for their contributions to this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Columbia University IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from the WHICAP or Offspring studies can be requested. https://www.cumc.columbia.edu/adrc/investigators ER -